Myelodysplastic Syndrome Related AML

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-07-23
Clinical Trial Update: A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Hematologic Malignancies (MK-8628-005) [Phase 1]
Phase 1 dose-exploration trial of Birabresib (MK-8628) in selected hematologic malignancies (AML variants and DLBCL) has been terminated wit…